SENSITIVE HPLC METHOD WITH FLUORESCENCE DETECTION AND ON-LINE WAVELENGTH SWITCHING FOR SIMULTANEOUS DETERMINATION OF VALSARTAN AND AMLODIPINE IN HUMAN PLASMA
- 1 December 2011
- journal article
- research article
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 34 (20) , 2583-2595
Abstract
This study describes the development and validation of a highly sensitive high-performance liquid chromatographic method with fluorescence detection and on-line emission wavelength switching for the simultaneous determination of valsartan (VAL) and amlodipine (AML) in human plasma. Irbesartan (IRB) was used as internal standard (IS). VAL, AML, and IRB were isolated from plasma by nonextractive procedure; simple protein precipitation with methanol. Separations were performed in low pressure gradient mode on Hypersil phenyl 120A analytical column using a mobile phase consisting of phosphate buffer (pH 4.0 ± 0.1):acetonitrile:methanol (60:30:10, v/v/v) at a flow rate of 0.8 mL/min. The detection of VAL and IRB (IS) was carried out at 253 nm (for excitation) and 374 nm (for emission). After elution of VAL and IRB, the detection wavelengths were switched on-line to 393 nm (excitation) and 446 nm (emission) for detection of AML. The linear ranges of the assay were 1–100 and 10–1000 ng/mL for VAL and AML, respectively. The limits of detection (LOD) were 0.3 and 1.6 ng/mL for VAL and AML, respectively. The intra- and inter-assay precisions were satisfactory; the relative standard deviations did not exceed 5.1%. The accuracy of the method was proved; the recovery of VAL and AML from spiked human plasma were 96.6–100.9 and 92.0–104.4% for VAL and AML, respectively. The method had higher throughput as it involved simple sample preparation procedure and short run-time (15 min). The results demonstrated that the proposed method would have great value in pharmacokinetic studies for VAL and AML.Keywords
This publication has 31 references indexed in Scilit:
- Simultaneous spectrofluorimetric determination of amlodipine besylate and valsartan in their combined tabletsDrug Testing and Analysis, 2010
- ValsartanDrugs, 2009
- Development and validation of a method for quantitative determination of valsartan in human plasma by liquid chromatography-tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2007
- Determination and pharmacokinetic study of amlodipine in human plasma by ultra performance liquid chromatography–electrospray ionization mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2007
- Validated HPLC method for determination of amlodipine in human plasma and its application to pharmacokinetic studiesIl Farmaco, 2005
- Application of oxidants to the spectrophotometric determination of amlodipine besylate in pharmaceutical formulationsIl Farmaco, 2004
- Simple and rapid HPLC method for determination of amlodipine in human serum with fluorescence detection and its use in pharmacokinetic studiesJournal of Pharmaceutical and Biomedical Analysis, 2004
- Sensitive spectrophotometric determination of amlodipine and felodipine using iron(III) and ferricyanideIl Farmaco, 2003
- Comparison of UV- and second derivative-spectrophotometric and LC methods for the determination of valsartan in pharmaceutical formulationJournal of Pharmaceutical and Biomedical Analysis, 2002
- ValsartanDrugs, 1997